Home/Publication/Blackstone Commences Takeover of I’rom, a Clinical Trial Services Provider
Blackstone Commences Takeover of I’rom, a Clinical Trial Services Provider 

03 Feb 2025

US$ 19.00

Blackstone Inc has launched a tender offer for the shares of I’rom Group Co Ltd, valuing the company at ¥33.9 billion (U...

Price / article: US$19.00
OR existing subscriber
Related Publications

TPG Inc (TPG) has sold part of its stake in Sai Life Sciences Ltd (Sai Life) and clocked 15 bn rupees (US$173.5 m) in...

TransThera Sciences (Nanjing) Inc (TransThera), a biopharmaceutical company backed by Morningside Ventures and CPE ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.